Localized Prostate Cancer
Clinical decision-making for localized prostate cancer depends heavily on toxicity and quality of life data rather than efficacy alone. The article states that no level 1 evidence shows survival superiority among EBRT, brachytherapy, and r…
1 sources - 5 claims
Clinical decision-making for localized prostate cancer depends heavily on toxicity and quality of life data rather than efficacy alone. The article states that no level 1 evidence shows survival superiority among EBRT, brachytherapy, and radical prostatectomy for localized prostate cancer. For localized prostate cancer, EBRT, brachytherapy, and radical prostatectomy are available radical treatment options.